文献速递分子诊断质量管理与危急值

分子诊断中的外部质量评估与替代评估程序:国际调查结果

External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey.
PubMed 文献 · Clin Chem Lab Med · 2020-05-08

国际临床化学与检验医学联合会分子诊断委员会(IFCC C-MD)对全球分子实验室开展调查,覆盖实验室自建检测(LDT)使用、外部质量评估(EQA)参与和替代评估程序(AAPs)执行情况。共收到来自亚洲、欧洲、中东、北美和南美的93份回复。

要点

  • 65.9%的参与实验室使用实验室自建检测(LDT)。
  • 81.3%的实验室报告强制参与EQA,22%未执行AAPs。

核心结论

  • 多数实验室执行EQA和AAPs以提升分子诊断质量,但AAPs作为质量程序在不同实验室间存在差异。
  • 需要进一步调查以明确对额外EQA和标准化AAPs的现有需求。

研究设计与样本

  • IFCC C-MD开展的国际调查,覆盖分子诊断服务特定主题及EQA和AAPs方法。
  • 调查内容涉及LDT使用、EQA参与和AAPs执行,共收到来自亚洲、欧洲、中东、北美和南美的93份实验室回复。

主要发现

  • 65.9%的参与实验室使用LDT。
  • 81.3%的实验室报告强制参与EQA项目。
  • 22%的实验室报告未执行AAPs。

关键数值与推荐

  • ISO 15189和CLSI QMS24要求参与EQA方案和AAPs(适用时)。

临床怎么用

  • 分子诊断实验室应参考ISO 15189和CLSI QMS24要求,参与EQA方案和AAPs以完善质量体系。

局限性

  • 调查基于93份回复,可能不能完全代表全球所有分子诊断实验室。
  • 需进一步调查以明确额外EQA和标准化AAPs的需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Quality management for clinical laboratories requires the establishment of internal procedures including standard operating procedures (SOPs), internal quality control (QC), validation of test results and quality assessment. External quality assessment (EQA) and alternativeassessment procedures (AAPs) are part of the quality hierarchy required for diagnostic testing. The International Organization for Standardization (ISO) document with requirements for conformance ISO 15189 and the Clinical and Laboratory Standards Institute document (CLSI) QMS24 require participation in EQA schemes and AAPs where applicable. The purpose of this study was to perform a global survey of EQA and AAPs for key procedures in molecular diagnostic laboratories. METHODS: The Committee for Molecular Diagnostics of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC C-MD) conducted a survey of international molecular laboratories that covered specific topics of molecular diagnostic services as well as methods for EQA and AAPs. The survey addressed the following aspects: (1) usage of laboratory-developed test (LDT), (2) participation in EQA schemes and (3) performance of AAPs. RESULTS: A total of 93 responses from laboratories located in Asia, Europe, the Middle East, North America and South America were received. The majority of the participating laboratories (65.9%) use LDTs and 81.3% stated that it is mandatory for them to participate in EQA programs, while 22% of the laboratories reported not performing AAPs. Thirty-one percent of the laboratories use EQAs for fewer than 50.0% of their reported parameters/analytes. CONCLUSIONS: While the majority of laboratories perform EQA and AAPs to improve their quality in molecular diagnostics, the amount of AAPs as quality procedures differs within the laboratories. Further surveys are necessary to clarify the existing needs in additional EQAs and standardized AAPs. The survey will also guide future efforts of the IFCC C-MD for identifying quality practices in need to improve harmonization and standardization within molecular diagnostics.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Payne DA, Russomando G, Linder MW, et al. External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey. Clin Chem Lab Med. 2020. PMID: 32383687. doi:10.1515/cclm-2020-0101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。